Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacotherapeutic conditioning of methotrexate in juvenile idiopathic arthritis
NL-OMON46548Phase 3Withdrawn
- Sponsor
- Leiden University
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methotrexate in juvenile idiopathic arthritis (JIA) (2 arms), sponsored by Leiden University. Primary endpoint: Methotrexate intolerance percentage. Planned start May 2018; status: withdrawn.
02
Drugs
methotrexate
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NL-OMON46548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46548.